A new breast cancer drug which has been succesfully trialled in Cornwall could soon be available for women on the NHS. The Royal Cornwall Hospital has been testing the drug, Perjeta, for the past seven years.
It's seen astounding results, with some women's tumours shrinking away. It's now been approved for use in cancer treatment in the UK and is awaiting formal clearance to be used on the NHS. Our Health Correspondent Jacquie Bird reports.